A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
- PMID: 8673089
- DOI: 10.1038/ng0596-117
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
Abstract
The BRCA2 gene on chromosome 13 has been shown to be associated with familial male and female breast cancer. Here we describe a study on BRCA2 in 21 Icelandic families, including 9 with male breast cancer. We have previously reported linkage to the BRCA2 region in an Icelandic male breast cancer family and subsequently found a strong indication of linkage to BRCA2 and the same BRCA2 haplotype in breast cancer cases from 15 additional families, indicating a common origin. We describe a five base-pair deletion in exon 9 of BRCA2 in an affected male from the male breast cancer family. The same mutation occurs in all the families with the shared BRCA2 haplotype indicating a founder effect. Among mutation carriers there are 12 males with breast cancer, which accounts for 40% of all males diagnosed with breast cancer in Iceland over the past 40 years. Three of them have no family history of breast cancer indicating that this mutation may have variable penetrance. The same BRCA2 mutation appears to be associated with different cancer phenotypes in this population including male and female breast cancer, prostate cancer, pancreas cancer and ovarian cancer.
Comment in
-
Breast cancer susceptibility testing: realities in the post-genomic era.Nat Genet. 1996 May;13(1):16-7. doi: 10.1038/ng0596-16. Nat Genet. 1996. PMID: 8673095 No abstract available.
Similar articles
-
A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.Cancer Res. 1996 Aug 1;56(15):3409-14. Cancer Res. 1996. PMID: 8758903
-
BRCA2 germline mutations in male breast cancer cases and breast cancer families.Nat Genet. 1996 May;13(1):123-5. doi: 10.1038/ng0596-123. Nat Genet. 1996. PMID: 8673091
-
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.Nat Genet. 1996 Mar;12(3):333-7. doi: 10.1038/ng0396-333. Nat Genet. 1996. PMID: 8589730
-
[Hereditary breast cancer: genetic bases and clinical features].Med Clin (Barc). 1994 Nov 12;103(16):623-7. Med Clin (Barc). 1994. PMID: 7996921 Review. Spanish. No abstract available.
-
Genetic and familial factors in cancer: a population perspective.IARC Sci Publ. 1982;(39):87-106. IARC Sci Publ. 1982. PMID: 6759390 Review. No abstract available.
Cited by
-
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.BMC Cancer. 2024 Apr 4;24(1):415. doi: 10.1186/s12885-024-12160-6. BMC Cancer. 2024. PMID: 38575974 Free PMC article.
-
Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients.NPJ Breast Cancer. 2023 Nov 30;9(1):95. doi: 10.1038/s41523-023-00600-8. NPJ Breast Cancer. 2023. PMID: 38036573 Free PMC article.
-
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.Cancers (Basel). 2022 Oct 26;14(21):5240. doi: 10.3390/cancers14215240. Cancers (Basel). 2022. PMID: 36358659 Free PMC article.
-
Computational Biology of BRCA2 in Male Breast Cancer, through Prediction of Probable nsSNPs, and Hit Identification.ACS Omega. 2022 Aug 17;7(34):30447-30461. doi: 10.1021/acsomega.2c03851. eCollection 2022 Aug 30. ACS Omega. 2022. PMID: 36061650 Free PMC article.
-
BRCA2 Haploinsufficiency in Telomere Maintenance.Genes (Basel). 2021 Dec 28;13(1):83. doi: 10.3390/genes13010083. Genes (Basel). 2021. PMID: 35052422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
